Auro Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
530233·NSE·Healthcare
Market Cap
149.90 Cr
PE Ratio
42.40
Volume
—
Day High - Low
—
52W High-Low
317.00 - 159.00
₹0.00▲ +0.00 (+0.00%)
Market Cap149.90 Cr
PE Ratio42.40
Volume—
Day High - Low—
52W High-Low317.00 - 159.00
Auro Laboratories Ltd (530233): company summary
Auro Laboratories Ltd (530233) is a micro-cap Healthcare company valued at ₹150 crore operating in Pharmaceuticals on the NSE and BSE.
Auro Laboratories Ltd (530233) is a micro-cap Healthcare company valued at ₹150 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -14.8% a year over three years; profit grew 12.8% a year, ahead of revenue — margins are expanding. Return on equity is 8.5%.
- Valuation multiples
- The stock trades at 42.4 times earnings, a premium to the Healthcare median of 32.5, 3.23 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.2/10
Poor
Fair Value
Sign in to see
ROE
8.49%
Average
P/E
42.40x
Expensive
Debt / Equity
1.37
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹159.00
₹317.00
DocStoX take
Held back by valuation (0.4). Scored on 4 of 5 measures.
DocStoX score
Medium confidence2.2
/10
Poor
Quality
Solid
ROE 8.5%
Valuation
Expensive
P/E 42.4×
Growth
Flat
Revenue -9.6% 5Y CAGR
Risk
High risk
D/E 1.37
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹150 Cr
52W High / Low
₹317 / ₹159
Dividend Yield
0.00%
Promoter Holding
52.40%
EPS (TTM)
₹2.95
Book Value
₹74.36
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 13% a year
- Revenue shrinking 10% a year
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Auro Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Auro Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Auro Laboratories Ltd with peers
Related tools & concepts
Value Auro Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing